España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Recursion Pharmaceuticals
RXRX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Q4 2024 earnings tomorrow on Fri Feb 28th before the market open
Conference call scheduled tomorrow at 8:30 AM
Click to view the webcast
Recursion Pharmaceuticals (RXRX) Forecast
News
Earnings
Recursion Pharmaceuticals (RXRX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Recursion Pharmaceuticals (NASDAQ:RXRX) Stock
Recursion Pharmaceuticals Stock (NASDAQ: RXRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, February 26, 2025
Spotlight on Recursion Pharmaceuticals: Analyzing the Surge in Options Activity
Benzinga Insights
Tuesday, February 18, 2025
Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Sunday, February 16, 2025
WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
Lekha Gupta
Friday, February 14, 2025
Recursion Pharmaceuticals shares are trading ...
Benzinga Newsdesk
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
SoftBank Group 13F Update: New 14.67M Share S...
Benzinga Newsdesk
Thursday, February 06, 2025
Where Recursion Pharmaceuticals Stands With Analysts
Benzinga Insights
Needham Reiterates Buy on Recursion Pharmaceu...
Benzinga Newsdesk
Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, February 05, 2025
Recursion Reports 12 Month Data From Phase 2 ...
Benzinga Newsdesk
Thursday, January 30, 2025
How Is The Market Feeling About Recursion Pharmaceuticals?
Benzinga Insights
Wednesday, January 22, 2025
Seagate Posts Upbeat Earnings, Joins Netflix, Travelers, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Saturday, January 11, 2025
Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce
Rounak Jain
Wednesday, January 08, 2025
Keybanc Maintains Overweight on Recursion Pha...
Benzinga Newsdesk
Tuesday, January 07, 2025
Recursion Pharmaceuticals Announces 2 Key Inv...
Benzinga Newsdesk
Saturday, January 04, 2025
Cathie Wood's Ark Invest Books Profits On Hot AI Stock Palantir, Sells Bitcoin ETF Shares As BTC Starts 2025 On A Positive Note
Rounak Jain
Thursday, January 02, 2025
Nio, Unity Software And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Wednesday, December 11, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Needham Reiterates Buy on Recursion Pharmaceu...
Benzinga Newsdesk
Tuesday, December 10, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Unpacking the Latest Options Trading Trends in Recursion Pharmaceuticals
Benzinga Insights
What's Going On With Recursion Pharmaceuticals Stock?
Adam Eckert
Monday, December 09, 2024
Recursion ReportsInitial Monotherapy Dose-esc...
Benzinga Newsdesk
Friday, December 06, 2024
Ulta Beauty Posts Upbeat Results, Joins Asana, Lululemon, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Wednesday, December 04, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Tuesday, December 03, 2024
Recursion Announces First Patient Dosed In Ph...
Benzinga Newsdesk
Monday, December 02, 2024
XPeng, NovoCure, Merus, Gap And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Top 10 Trending Stocks On WallStreetBets As O...
Benzinga Newsdesk
Thursday, November 28, 2024
(RXRX) - Analyzing Recursion Pharmaceuticals's Short Interest
Benzinga Insights
Wednesday, November 27, 2024
Jim Cramer: Reddit Is 'Fabulous,' Dow Is A 'Tough' One
Avi Kapoor
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
Kaustubh Bagalkote
Wednesday, November 20, 2024
Needham Reiterates Buy on Recursion Pharmaceu...
Benzinga Newsdesk
Friday, November 15, 2024
Nvidia Reveals 3.6% Stake In Applied Digital, Stock Soars
Anusuya Lahiri
Thursday, November 14, 2024
Nvidia 13F Shows Decreased Stake In Arm Holdi...
Benzinga Newsdesk
Wednesday, November 13, 2024
Recursion And Exscientia Receive Shareholder ...
Benzinga Newsdesk
Monday, November 11, 2024
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Thursday, November 07, 2024
A Closer Look at 4 Analyst Recommendations For Recursion Pharmaceuticals
Benzinga Insights
Needham Reiterates Buy on Recursion Pharmaceu...
Benzinga Newsdesk
Wednesday, November 06, 2024
Recursion Pharmaceuticals Q3 2024 GAAP EPS $(...
Benzinga Newsdesk
Monday, November 04, 2024
Peering Into Recursion Pharmaceuticals's Recent Short Interest
Benzinga Insights
10 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Thursday, October 31, 2024
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Chris Katje
Tuesday, October 22, 2024
Recursion Doses First Patient In Phase 2 Stud...
Benzinga Newsdesk
Wednesday, October 02, 2024
Recursion Announces FDA Clearance If Investig...
Benzinga Newsdesk
Monday, September 16, 2024
Looking Into Recursion Pharmaceuticals's Recent Short Interest
Benzinga Insights
Wednesday, September 04, 2024
Decoding 6 Analyst Evaluations For Recursion Pharmaceuticals
Benzinga Insights
Needham Maintains Buy on Recursion Pharmaceut...
Benzinga Newsdesk
Tuesday, September 03, 2024
Crude Oil Dips Over 4%; SPAR Group Shares Spike Higher
Avi Kapoor
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Jefferies Maintains Hold on Recursion Pharmac...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
